Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013
In a significant move, New Zealand’s Medsafe has reclassified cannabidiol (CBD), a medicinal cannabis product, from a prescription-only medicine to a restricted medicine available at pharmacies. This change aligns New Zealand with Australia’s approach, which underwent a similar modification in December 2020. While currently, no CBD products are approved in New Zealand, this reclassification opens
READ MOREIn a bold move against the state’s steep fee hikes, a Florida medical marijuana retailer is taking a stand. The company is contesting a $1.3 million biennial renewal fee—an increase that has been described as ‘exponential’. This fee, endorsed by Governor Ron DeSantis, has sparked a significant debate over the barriers to entry and sustainability
READ MOREIn a significant development, the UK government is reassessing its position on Cannabidiol (CBD) after receiving expert guidance on the compound. CBD, known for its non-psychoactive properties, is one of the numerous cannabinoids found in the cannabis plant. This reevaluation could pave the way for new regulations and an updated framework that may alter the
READ MOREIn a unique educational setting, the Cleveland School of Cannabis is preparing students for careers in the burgeoning marijuana industry. Unlike traditional colleges, the school offers hands-on experience in its grow room, dispensary, and cooking lab. Nicole Fenix, the school’s director of education, emphasizes that the institution is not just about smoking marijuana but is
READ MORE